Acebutolol

CHEMBL642 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
336.4 g/mol
LogP
1.7
Phase
4

A beta-blocker that slows the heart rate and reduces the force of heartbeats by blocking the effects of adrenaline on the heart. It is used to treat high blood pressure and certain types of irregular heart rhythms, particularly fast heartbeats originating in the upper chambers of the heart. Patients should not stop taking it suddenly, as abrupt withdrawal can trigger rebound increases in heart rate and blood pressure.

Berat Molekul

336,4000 g/mol

LogP

1,70

TPSA

87,70 Ų

Lipinski RO5

Lulus

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1

InChI

InChI=1S/C18H28N2O4/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3/h7-9,12,15,19,22H,5-6,10-11H2,1-4H3,(H,20,23)

Molecular Formula

C18H28N2O4

HBD / HBA

3 / 5

Ikatan yang Dapat Dirotasi

10

Atom Berat

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A beta-blocker that slows the heart rate and reduces the force of heartbeats by blocking the effects of adrenaline on the heart. It is used to treat high blood pressure and certain types of irregular heart rhythms, particularly fast heartbeats originating in the upper chambers of the heart. Patients should not stop taking it suddenly, as abrupt withdrawal can trigger rebound increases in heart rate and blood pressure.

Yes, Acebutolol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL642. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 1978. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.